Medicine and Dentistry
Cystic Fibrosis
87%
Bronchiectasis
85%
Lung Transplantation
68%
Combination Therapy
58%
Infection
54%
Inpatient
40%
Chronic Respiratory Tract Disease
34%
Interleukin 13
34%
Substitution Therapy
34%
Hypogammaglobulinemia
34%
Immunoglobulin
34%
Reimbursement
34%
Treatment Response
34%
Antibodies
34%
Antibody Mediated Rejection
34%
Medicare
34%
Mitral Valve
34%
Forced Expiratory Volume
34%
Antibiotics
25%
Human Leukocyte Antigen
25%
Asthma
20%
Diseases
18%
Atypical Mycobacterium
17%
Antibiotic Therapy
17%
Patient
16%
Computer Assisted Tomography
15%
Therapeutic Procedure
14%
Treatment of Asthma
13%
Transcription Factor RUNX2
13%
Disease Marker
13%
Antibody Response
12%
Lung
11%
Sputum
9%
Primary Health Care
9%
Tissues
8%
Methicillin Resistant Staphylococcus Aureus
8%
Pathogen
8%
Burkholderia
8%
Host
8%
Antiinfective Agent
8%
Species
8%
Mechanism of Action
8%
Development
8%
Inhalation
8%
Respiratory System
8%
Pseudomonas aeruginosa
8%
Allograft
7%
Receptor
6%
Cell Type
6%
T-Helper Cell
6%
Lung Function
6%
Immunoglobulin E
6%
Mediator
6%
Protein
6%
Fibrosis
6%
Monoclonal Antibody
6%
Airway Remodeling
6%
Serositis
6%
Eosinophil
6%
Interleukin 4
6%
Lung Infection
6%
Prevalence
6%
Diagnosis
6%
Adult
6%
Coughing
6%
Respiratory Tract Infection
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
100%
Bronchiectasis
77%
Antibiotic Agent
51%
Chronic Respiratory Tract Disease
34%
Dexamethasone
34%
Methylprednisolone
34%
Interleukin 13
34%
Immunoglobulin Deficiency
34%
Antibody
34%
Lebrikizumab
27%
Infection
25%
Ventilator Associated Pneumonia
25%
Asthma
20%
Atypical Mycobacterium
17%
Adult Respiratory Distress Syndrome
17%
Corticosteroid
17%
Mortality
17%
Adverse Event
14%
Disease Marker
13%
Transcription Factor RUNX2
13%
Diseases
11%
Respiratory Tract Disease
11%
Cohort Study
11%
Antiinfective Agent
8%
Methicillin-Resistant Staphylococcus Aureus
8%
Pseudomonas aeruginosa
8%
Host
8%
Burkholderia
8%
Organisms
8%
Infectious Agent
8%
Ensure
8%
Hospital Infection
8%
Bacterial Infection
8%
Antibiotics
8%
Protein
6%
Interleukin 4
6%
Airway Remodeling
6%
Monoclonal Antibody
6%
Fibrosis
6%
Immunoglobulin E
6%
Receptor
6%
Lung Infection
6%
Prevalence
6%
Clinical Trial
5%
Retrospective Study
5%
Intubation
5%
Disease Severity
5%
Pneumonia
5%
Insulin
5%
Hypertensive Factor
5%
Organ Dysfunction Score
5%
Death
5%
Secondary Infection
5%
Nursing and Health Professions
Cystic Fibrosis
56%
Bronchiectasis
51%
Deterioration
34%
Antibody
34%
Forced Expiratory Volume
34%
Antibiotic Agent
25%
Systolic Blood Pressure
22%
Infection
20%
Low Density Lipoprotein Cholesterol Level
19%
Antibiotic Therapy
17%
Patient
17%
Diseases
12%
Glucose Level
11%
Aerosol
8%
Methicillin-Resistant Staphylococcus Aureus
8%
Electric Potential
8%
Species
8%
Bacterial Load
8%
Clinical Practice
8%
Antiinfective Agent
8%
Nebulization
8%
Cohort Analysis
7%
Glucose
7%
Apolipoprotein E4
7%
Health Care System
6%
Syndrome
6%
Elderly Population
6%